nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—hepatitis B	0.728	0.889	CbGaD
Naloxone—ALB—hepatitis B	0.0909	0.111	CbGaD
Naloxone—CREB1—blood plasma—hepatitis B	0.00372	0.2	CbGeAlD
Naloxone—CREB1—Gemcitabine—Lamivudine—hepatitis B	0.00364	1	CbGdCrCtD
Naloxone—TLR4—blood—hepatitis B	0.00309	0.166	CbGeAlD
Naloxone—Rhinorrhoea—Telbivudine—hepatitis B	0.00286	0.063	CcSEcCtD
Naloxone—TLR4—liver—hepatitis B	0.00242	0.13	CbGeAlD
Naloxone—Abdominal cramps—Lamivudine—hepatitis B	0.00193	0.0426	CcSEcCtD
Naloxone—Rhinorrhoea—Lamivudine—hepatitis B	0.00161	0.0355	CcSEcCtD
Naloxone—Nasopharyngitis—Telbivudine—hepatitis B	0.0015	0.0331	CcSEcCtD
Naloxone—CREB1—blood—hepatitis B	0.00136	0.0731	CbGeAlD
Naloxone—Mental disorder—Entecavir—hepatitis B	0.00124	0.0273	CcSEcCtD
Naloxone—CYP2C8—blood plasma—hepatitis B	0.00121	0.0647	CbGeAlD
Naloxone—CREB1—liver—hepatitis B	0.00107	0.0572	CbGeAlD
Naloxone—Mediastinal disorder—Telbivudine—hepatitis B	0.00105	0.0231	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00104	0.023	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00102	0.0224	CcSEcCtD
Naloxone—Nervous system disorder—Entecavir—hepatitis B	0.000985	0.0217	CcSEcCtD
Naloxone—Skin disorder—Entecavir—hepatitis B	0.000976	0.0215	CcSEcCtD
Naloxone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000961	0.0212	CcSEcCtD
Naloxone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000952	0.021	CcSEcCtD
Naloxone—Gastrointestinal disorder—Entecavir—hepatitis B	0.000868	0.0191	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000855	0.0189	CcSEcCtD
Naloxone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000846	0.0187	CcSEcCtD
Naloxone—Nasopharyngitis—Lamivudine—hepatitis B	0.000846	0.0187	CcSEcCtD
Naloxone—CYP3A4—blood plasma—hepatitis B	0.000817	0.0438	CbGeAlD
Naloxone—Nervous system disorder—Telbivudine—hepatitis B	0.00081	0.0179	CcSEcCtD
Naloxone—Skin disorder—Telbivudine—hepatitis B	0.000802	0.0177	CcSEcCtD
Naloxone—Abdominal pain—Entecavir—hepatitis B	0.000794	0.0175	CcSEcCtD
Naloxone—Body temperature increased—Entecavir—hepatitis B	0.000794	0.0175	CcSEcCtD
Naloxone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000775	0.0171	CcSEcCtD
Naloxone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000775	0.0171	CcSEcCtD
Naloxone—Paraesthesia—Telbivudine—hepatitis B	0.000741	0.0164	CcSEcCtD
Naloxone—OPRM1—blood—hepatitis B	0.000735	0.0394	CbGeAlD
Naloxone—Depression—Lamivudine—hepatitis B	0.000727	0.016	CcSEcCtD
Naloxone—Asthenia—Entecavir—hepatitis B	0.000721	0.0159	CcSEcCtD
Naloxone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000713	0.0157	CcSEcCtD
Naloxone—Pain—Telbivudine—hepatitis B	0.000706	0.0156	CcSEcCtD
Naloxone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000703	0.0155	CcSEcCtD
Naloxone—Sweating—Lamivudine—hepatitis B	0.000699	0.0154	CcSEcCtD
Naloxone—Diarrhoea—Entecavir—hepatitis B	0.000688	0.0152	CcSEcCtD
Naloxone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000671	0.0148	CcSEcCtD
Naloxone—Body temperature increased—Telbivudine—hepatitis B	0.000653	0.0144	CcSEcCtD
Naloxone—Abdominal pain—Telbivudine—hepatitis B	0.000653	0.0144	CcSEcCtD
Naloxone—Vomiting—Entecavir—hepatitis B	0.000639	0.0141	CcSEcCtD
Naloxone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000623	0.0138	CcSEcCtD
Naloxone—Nausea—Entecavir—hepatitis B	0.000597	0.0132	CcSEcCtD
Naloxone—Asthenia—Telbivudine—hepatitis B	0.000592	0.0131	CcSEcCtD
Naloxone—Mediastinal disorder—Lamivudine—hepatitis B	0.00059	0.013	CcSEcCtD
Naloxone—Chills—Lamivudine—hepatitis B	0.000588	0.013	CcSEcCtD
Naloxone—Nausea—Adefovir Dipivoxil—hepatitis B	0.000582	0.0128	CcSEcCtD
Naloxone—ABCB1—blood plasma—hepatitis B	0.000578	0.031	CbGeAlD
Naloxone—Diarrhoea—Telbivudine—hepatitis B	0.000565	0.0125	CcSEcCtD
Naloxone—Tension—Lamivudine—hepatitis B	0.000559	0.0123	CcSEcCtD
Naloxone—Nervousness—Lamivudine—hepatitis B	0.000554	0.0122	CcSEcCtD
Naloxone—ESR1—blood—hepatitis B	0.000536	0.0288	CbGeAlD
Naloxone—Tremor—Lamivudine—hepatitis B	0.000534	0.0118	CcSEcCtD
Naloxone—Vomiting—Telbivudine—hepatitis B	0.000525	0.0116	CcSEcCtD
Naloxone—SLCO1A2—liver—hepatitis B	0.000494	0.0265	CbGeAlD
Naloxone—Convulsion—Lamivudine—hepatitis B	0.000494	0.0109	CcSEcCtD
Naloxone—ALB—liver—hepatitis B	0.000492	0.0264	CbGeAlD
Naloxone—Nausea—Telbivudine—hepatitis B	0.00049	0.0108	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000482	0.0106	CcSEcCtD
Naloxone—Nervous system disorder—Lamivudine—hepatitis B	0.000456	0.0101	CcSEcCtD
Naloxone—Skin disorder—Lamivudine—hepatitis B	0.000452	0.00997	CcSEcCtD
Naloxone—Hyperhidrosis—Lamivudine—hepatitis B	0.00045	0.00992	CcSEcCtD
Naloxone—CYP2C8—blood—hepatitis B	0.000442	0.0237	CbGeAlD
Naloxone—ESR1—liver—hepatitis B	0.000419	0.0225	CbGeAlD
Naloxone—Paraesthesia—Lamivudine—hepatitis B	0.000418	0.00922	CcSEcCtD
Naloxone—Dyspnoea—Lamivudine—hepatitis B	0.000415	0.00915	CcSEcCtD
Naloxone—Buprenorphine—CYP2A6—hepatitis B	0.000409	1	CrCbGaD
Naloxone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000402	0.00886	CcSEcCtD
Naloxone—Pain—Lamivudine—hepatitis B	0.000398	0.00878	CcSEcCtD
Naloxone—Abdominal pain—Lamivudine—hepatitis B	0.000368	0.00811	CcSEcCtD
Naloxone—Body temperature increased—Lamivudine—hepatitis B	0.000368	0.00811	CcSEcCtD
Naloxone—CYP2C8—liver—hepatitis B	0.000345	0.0185	CbGeAlD
Naloxone—Asthenia—Lamivudine—hepatitis B	0.000334	0.00736	CcSEcCtD
Naloxone—Diarrhoea—Lamivudine—hepatitis B	0.000318	0.00702	CcSEcCtD
Naloxone—CYP3A4—blood—hepatitis B	0.000299	0.0161	CbGeAlD
Naloxone—Vomiting—Lamivudine—hepatitis B	0.000296	0.00653	CcSEcCtD
Naloxone—Nausea—Lamivudine—hepatitis B	0.000276	0.0061	CcSEcCtD
Naloxone—CYP3A4—liver—hepatitis B	0.000234	0.0126	CbGeAlD
Naloxone—ABCB1—blood—hepatitis B	0.000212	0.0114	CbGeAlD
Naloxone—ABCB1—liver—hepatitis B	0.000166	0.00889	CbGeAlD
Naloxone—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	4.36e-05	0.000384	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—IL6—hepatitis B	4.35e-05	0.000383	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—F2—hepatitis B	4.34e-05	0.000382	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTNNB1—hepatitis B	4.33e-05	0.000382	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—IL6—hepatitis B	4.33e-05	0.000381	CbGpPWpGaD
Naloxone—CREB1—Immune System—HSPA5—hepatitis B	4.31e-05	0.00038	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCR5—hepatitis B	4.27e-05	0.000377	CbGpPWpGaD
Naloxone—TLR4—Immune System—CDKN1A—hepatitis B	4.23e-05	0.000373	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SAG—hepatitis B	4.23e-05	0.000373	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RIT2—hepatitis B	4.23e-05	0.000373	CbGpPWpGaD
Naloxone—TLR4—Immune System—PTEN—hepatitis B	4.22e-05	0.000372	CbGpPWpGaD
Naloxone—TLR4—Immune System—NFKB1—hepatitis B	4.2e-05	0.00037	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CXCL10—hepatitis B	4.2e-05	0.00037	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.18e-05	0.000369	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—TLR4—hepatitis B	4.15e-05	0.000366	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.12e-05	0.000363	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—IL6—hepatitis B	4.07e-05	0.000359	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—IL6—hepatitis B	4.07e-05	0.000359	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	4.07e-05	0.000359	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DPB1—hepatitis B	4.07e-05	0.000359	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—IL6—hepatitis B	4.03e-05	0.000356	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TGFB1—hepatitis B	4.03e-05	0.000355	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.02e-05	0.000355	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	4.02e-05	0.000354	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—hepatitis B	4.02e-05	0.000354	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4.01e-05	0.000354	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—IL6—hepatitis B	4e-05	0.000352	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	4e-05	0.000352	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DRB1—hepatitis B	3.98e-05	0.000351	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—IL6—hepatitis B	3.98e-05	0.000351	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR2—hepatitis B	3.91e-05	0.000345	CbGpPWpGaD
Naloxone—CREB1—Disease—GOT2—hepatitis B	3.88e-05	0.000342	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNB1—hepatitis B	3.88e-05	0.000342	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	3.87e-05	0.000341	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—hepatitis B	3.87e-05	0.000341	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	3.84e-05	0.000339	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CXCL10—hepatitis B	3.83e-05	0.000337	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CXCL10—hepatitis B	3.81e-05	0.000336	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNA1—hepatitis B	3.79e-05	0.000334	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SAG—hepatitis B	3.75e-05	0.000331	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RIT2—hepatitis B	3.75e-05	0.000331	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CXCL10—hepatitis B	3.68e-05	0.000325	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—IL6—hepatitis B	3.68e-05	0.000324	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—F2—hepatitis B	3.67e-05	0.000323	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	3.6e-05	0.000318	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TGFB1—hepatitis B	3.57e-05	0.000315	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL6—hepatitis B	3.54e-05	0.000312	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD14—hepatitis B	3.53e-05	0.000311	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNA2—hepatitis B	3.53e-05	0.000311	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.51e-05	0.000309	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—hepatitis B	3.49e-05	0.000308	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.48e-05	0.000307	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	3.4e-05	0.0003	CbGpPWpGaD
Naloxone—CREB1—Disease—GOT1—hepatitis B	3.35e-05	0.000296	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL10—hepatitis B	3.34e-05	0.000295	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—hepatitis B	3.33e-05	0.000294	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.33e-05	0.000293	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—hepatitis B	3.31e-05	0.000291	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CCR5—hepatitis B	3.26e-05	0.000287	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HSPA5—hepatitis B	3.25e-05	0.000286	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—HNF4A—hepatitis B	3.22e-05	0.000284	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL10—hepatitis B	3.11e-05	0.000274	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.11e-05	0.000274	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—IL6—hepatitis B	3.01e-05	0.000265	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL18—hepatitis B	3.01e-05	0.000265	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD40LG—hepatitis B	3e-05	0.000264	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CCR5—hepatitis B	2.97e-05	0.000262	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD8A—hepatitis B	2.96e-05	0.000261	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCR5—hepatitis B	2.96e-05	0.000261	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CTNNB1—hepatitis B	2.94e-05	0.000259	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IFNB1—hepatitis B	2.93e-05	0.000258	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—hepatitis B	2.92e-05	0.000258	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP2A6—hepatitis B	2.91e-05	0.000257	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IFNA1—hepatitis B	2.86e-05	0.000252	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CCR5—hepatitis B	2.86e-05	0.000252	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NFKB1—hepatitis B	2.85e-05	0.000251	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL10—hepatitis B	2.83e-05	0.000249	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL6—hepatitis B	2.81e-05	0.000248	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—hepatitis B	2.81e-05	0.000247	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—F2—hepatitis B	2.79e-05	0.000246	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—hepatitis B	2.77e-05	0.000244	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.74e-05	0.000242	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.72e-05	0.000239	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IFNA2—hepatitis B	2.66e-05	0.000234	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-A—hepatitis B	2.64e-05	0.000233	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—hepatitis B	2.64e-05	0.000233	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GOT2—hepatitis B	2.63e-05	0.000232	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTNNB1—hepatitis B	2.6e-05	0.000229	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCR5—hepatitis B	2.59e-05	0.000229	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ALB—hepatitis B	2.58e-05	0.000228	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—F2—hepatitis B	2.55e-05	0.000224	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—F2—hepatitis B	2.54e-05	0.000224	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CDKN1A—hepatitis B	2.54e-05	0.000224	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PTEN—hepatitis B	2.53e-05	0.000223	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NFKB1—hepatitis B	2.52e-05	0.000222	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—hepatitis B	2.51e-05	0.000221	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.51e-05	0.000221	CbGpPWpGaD
Naloxone—CREB1—Disease—CCR5—hepatitis B	2.5e-05	0.000221	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.49e-05	0.00022	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKR1B1—hepatitis B	2.46e-05	0.000217	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—F2—hepatitis B	2.45e-05	0.000216	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKR1B1—hepatitis B	2.45e-05	0.000216	CbGpPWpGaD
Naloxone—CREB1—Disease—HLA-A—hepatitis B	2.44e-05	0.000215	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDKN1A—hepatitis B	2.44e-05	0.000215	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PTEN—hepatitis B	2.43e-05	0.000214	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NFKB1—hepatitis B	2.42e-05	0.000213	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR4—hepatitis B	2.42e-05	0.000213	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CCR5—hepatitis B	2.41e-05	0.000213	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DRB1—hepatitis B	2.41e-05	0.000213	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—hepatitis B	2.38e-05	0.000209	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GGT2—hepatitis B	2.36e-05	0.000208	CbGpPWpGaD
Naloxone—ALB—Metabolism—GGT2—hepatitis B	2.35e-05	0.000207	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	2.29e-05	0.000202	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GOT1—hepatitis B	2.27e-05	0.0002	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GGT1—hepatitis B	2.27e-05	0.0002	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL10—hepatitis B	2.26e-05	0.000199	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL10—hepatitis B	2.25e-05	0.000199	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—F2—hepatitis B	2.23e-05	0.000196	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—hepatitis B	2.22e-05	0.000196	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCR5—hepatitis B	2.19e-05	0.000193	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.18e-05	0.000192	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKR1B1—hepatitis B	2.15e-05	0.000189	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.13e-05	0.000188	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.12e-05	0.000187	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS2—hepatitis B	2.12e-05	0.000187	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.11e-05	0.000186	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.07e-05	0.000183	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—F2—hepatitis B	2.07e-05	0.000183	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGT2—hepatitis B	2.06e-05	0.000181	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL10—hepatitis B	1.98e-05	0.000174	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL2—hepatitis B	1.88e-05	0.000166	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—F2—hepatitis B	1.88e-05	0.000166	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—hepatitis B	1.79e-05	0.000158	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.79e-05	0.000158	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNG—hepatitis B	1.76e-05	0.000155	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.76e-05	0.000155	CbGpPWpGaD
Naloxone—ALB—Hemostasis—F2—hepatitis B	1.75e-05	0.000155	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCR5—hepatitis B	1.75e-05	0.000155	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCR5—hepatitis B	1.75e-05	0.000154	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS2—hepatitis B	1.73e-05	0.000153	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL2—hepatitis B	1.71e-05	0.000151	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL2—hepatitis B	1.71e-05	0.000151	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—hepatitis B	1.7e-05	0.00015	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL10—hepatitis B	1.67e-05	0.000147	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL2—hepatitis B	1.65e-05	0.000145	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.64e-05	0.000145	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—hepatitis B	1.58e-05	0.000139	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—hepatitis B	1.57e-05	0.000139	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2—hepatitis B	1.57e-05	0.000138	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR5—hepatitis B	1.53e-05	0.000135	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTNNB1—hepatitis B	1.51e-05	0.000133	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—F2—hepatitis B	1.5e-05	0.000133	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—F2—hepatitis B	1.5e-05	0.000132	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2—hepatitis B	1.5e-05	0.000132	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL10—hepatitis B	1.48e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDKN1A—hepatitis B	1.48e-05	0.00013	CbGpPWpGaD
Naloxone—CREB1—Immune System—PTEN—hepatitis B	1.47e-05	0.00013	CbGpPWpGaD
Naloxone—CREB1—Immune System—NFKB1—hepatitis B	1.47e-05	0.000129	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.45e-05	0.000128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP2A6—hepatitis B	1.43e-05	0.000126	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP2A6—hepatitis B	1.42e-05	0.000125	CbGpPWpGaD
Naloxone—CREB1—Disease—CTNNB1—hepatitis B	1.4e-05	0.000123	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2—hepatitis B	1.39e-05	0.000123	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN1A—hepatitis B	1.36e-05	0.00012	CbGpPWpGaD
Naloxone—CREB1—Disease—PTEN—hepatitis B	1.36e-05	0.00012	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.33e-05	0.000118	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.32e-05	0.000117	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—F2—hepatitis B	1.31e-05	0.000116	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR5—hepatitis B	1.3e-05	0.000114	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GOT2—hepatitis B	1.29e-05	0.000114	CbGpPWpGaD
Naloxone—ALB—Metabolism—GOT2—hepatitis B	1.29e-05	0.000113	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGT2—hepatitis B	1.27e-05	0.000112	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2—hepatitis B	1.27e-05	0.000112	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP2A6—hepatitis B	1.25e-05	0.00011	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALB—hepatitis B	1.21e-05	0.000107	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2—hepatitis B	1.18e-05	0.000104	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR5—hepatitis B	1.15e-05	0.000101	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—hepatitis B	1.13e-05	9.95e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GOT2—hepatitis B	1.13e-05	9.94e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GOT1—hepatitis B	1.12e-05	9.85e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GGT1—hepatitis B	1.12e-05	9.85e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—F2—hepatitis B	1.11e-05	9.8e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GOT1—hepatitis B	1.11e-05	9.79e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GGT1—hepatitis B	1.11e-05	9.79e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.11e-05	9.74e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.02e-05	8.98e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2—hepatitis B	1.01e-05	8.93e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.01e-05	8.92e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2—hepatitis B	1.01e-05	8.9e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—hepatitis B	1.01e-05	8.88e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—hepatitis B	1e-05	8.86e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—F2—hepatitis B	9.85e-06	8.69e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CTNNB1—hepatitis B	9.78e-06	8.62e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CTNNB1—hepatitis B	9.75e-06	8.59e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGT1—hepatitis B	9.73e-06	8.58e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GOT1—hepatitis B	9.73e-06	8.58e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN1A—hepatitis B	9.55e-06	8.42e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTEN—hepatitis B	9.53e-06	8.4e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN1A—hepatitis B	9.52e-06	8.39e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTEN—hepatitis B	9.5e-06	8.38e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NFKB1—hepatitis B	9.48e-06	8.36e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NFKB1—hepatitis B	9.45e-06	8.33e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTEN—hepatitis B	9.23e-06	8.13e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—hepatitis B	9.22e-06	8.13e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—hepatitis B	9.21e-06	8.12e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2—hepatitis B	8.85e-06	7.81e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—hepatitis B	8.81e-06	7.77e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CTNNB1—hepatitis B	8.55e-06	7.53e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—hepatitis B	8.5e-06	7.5e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN1A—hepatitis B	8.35e-06	7.36e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTEN—hepatitis B	8.33e-06	7.34e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NFKB1—hepatitis B	8.29e-06	7.31e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—hepatitis B	7.9e-06	6.97e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—hepatitis B	7.88e-06	6.94e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2A6—hepatitis B	7.68e-06	6.77e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—hepatitis B	7.59e-06	6.69e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2—hepatitis B	7.48e-06	6.6e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—hepatitis B	7.45e-06	6.56e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CTNNB1—hepatitis B	7.22e-06	6.37e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN1A—hepatitis B	7.06e-06	6.22e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTEN—hepatitis B	7.04e-06	6.21e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NFKB1—hepatitis B	7.01e-06	6.18e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT2—hepatitis B	6.95e-06	6.12e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—hepatitis B	6.91e-06	6.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2—hepatitis B	6.63e-06	5.85e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—hepatitis B	6.5e-06	5.73e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—hepatitis B	6.48e-06	5.72e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CTNNB1—hepatitis B	6.4e-06	5.65e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN1A—hepatitis B	6.26e-06	5.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTEN—hepatitis B	6.24e-06	5.5e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NFKB1—hepatitis B	6.21e-06	5.48e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGT1—hepatitis B	6e-06	5.29e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT1—hepatitis B	6e-06	5.29e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—hepatitis B	5.95e-06	5.25e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—hepatitis B	5.94e-06	5.24e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—hepatitis B	5.93e-06	5.23e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—hepatitis B	5.84e-06	5.15e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—hepatitis B	5.69e-06	5.01e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—hepatitis B	5.2e-06	4.59e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—hepatitis B	5.18e-06	4.56e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—hepatitis B	5.18e-06	4.56e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—hepatitis B	4.81e-06	4.24e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTEN—hepatitis B	4.53e-06	4e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTEN—hepatitis B	4.51e-06	3.97e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—hepatitis B	4.4e-06	3.88e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—hepatitis B	4.26e-06	3.76e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTEN—hepatitis B	3.95e-06	3.48e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—hepatitis B	3.9e-06	3.44e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—hepatitis B	3.19e-06	2.81e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTEN—hepatitis B	2.43e-06	2.15e-05	CbGpPWpGaD
